These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1895529)

  • 21. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive supranuclear palsy: MRI and pathological findings.
    Yagishita A; Oda M
    Neuroradiology; 1996 May; 38 Suppl 1():S60-6. PubMed ID: 8811682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal cell loss of the striatonigral system in multiple system atrophy.
    Kume A; Takahashi A; Hashizume Y
    J Neurol Sci; 1993 Jul; 117(1-2):33-40. PubMed ID: 8410064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nurr1 in Parkinson's disease and related disorders.
    Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
    J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease.
    Ma SY; Rinne JO; Collan Y; Röyttä M; Rinne UK
    J Neurol Sci; 1996 Sep; 140(1-2):40-5. PubMed ID: 8866425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.
    Inoue M; Yagishita S; Ryo M; Hasegawa K; Amano N; Matsushita M
    Acta Neuropathol; 1997 Jun; 93(6):585-91. PubMed ID: 9194897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism.
    Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K
    J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The reappraisal study of the ultrastructure of Alzheimer's neurofibrillary tangles in three cases of progressive supranuclear palsy].
    Amano N; Iwabuchi K; Yokoi S; Yagishita S; Itoh Y; Saitoh A; Nagatomo H; Matsushita M
    No To Shinkei; 1989 Jan; 41(1):35-44. PubMed ID: 2655673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human substantia nigra and ventral tegmental area. A neuroanatomical study with notes on aging and aging diseases.
    van Domburg PH; ten Donkelaar HJ
    Adv Anat Embryol Cell Biol; 1991; 121():1-132. PubMed ID: 2053466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
    Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW
    Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substantia nigra echogenicity in progressive supranuclear palsy.
    Ebentheuer J; Canelo M; Trautmann E; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):773-7. PubMed ID: 20198715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.
    Tsuboi Y; Ahlskog JE; Apaydin H; Parisi JE; Dickson DW
    Neurology; 2001 Nov; 57(9):1675-8. PubMed ID: 11706110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease.
    Tooyama I; McGeer EG; Kawamata T; Kimura H; McGeer PL
    Brain Res; 1994 Sep; 656(1):165-8. PubMed ID: 7804831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ageing and Parkinson's disease: substantia nigra regional selectivity.
    Fearnley JM; Lees AJ
    Brain; 1991 Oct; 114 ( Pt 5)():2283-301. PubMed ID: 1933245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain.
    Yamada M; Yamada M; Richelson E
    Neuroscience; 1995 Jan; 64(2):405-17. PubMed ID: 7700529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.